COTA, Miami Cancer Institute: real-world data partnership
Real-world data and analytics company COTA has announced an expansion of its partnership with the Miami Cancer Institute, which aims to improve standard of care and access for minority cancer patient populations. The institute will use COTA’s analytics platform to improve understanding on how various factors contribute to disparities.
Leonard Kalman, MD, Miami Cancer Institute’s executive deputy director and chief medical officer, said, “Delayed cancer diagnosis for a patient frequently leads to poorer outcomes. Our hope is that this collaborative research will identify the patients who are most at-risk for delayed diagnosis so we can increase education and expand access to routine cancer screenings for these populations.”
